High-Potency Chemotherapy for Leukemia and Lymphoma | Hospital-Grade Multi-Dose Vial
Cytarabine Injection 1000 mg per 50 mL by Pfizer Injectables is a hospital-trusted, prescription-only chemotherapy agent designed for precision dosing and broad-spectrum antineoplastic activity. Used as a cornerstone in the treatment of hematologic malignancies, this multi-dose vial delivers dependable, measurable, and cost-effective therapy for cancer centers and hospital pharmacies nationwide.
Primary Indications/Uses:
- Acute Myeloid Leukemia (AML)
- Acute Lymphocytic Leukemia (ALL)
- Chronic Myelogenous Leukemia (CML) – Blast Phase
- Non-Hodgkin’s Lymphoma (NHL)
- Meningeal Leukemia/Lymphoma (CNS Prophylaxis or Treatment)
- Other Physician-Guided Cancer Protocols
Key Features & Benefits:
- Concentrated 1000 mg Cytarabine in 50 mL Multi-Dose Vial
-
Essential Chemotherapy Drug for Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), and Non-Hodgkin’s Lymphoma (NHL)
- Sterile, Preservative-Free Hospital-Grade Solution
- Trusted by Oncologists and Cancer Centers Worldwide
- Reliable, Consistent Dosing For IV, Subcutaneous, or Intrathecal Use
- Manufactured & Quality-Tested by Pfizer Injectables – Industry Leaders in Oncology Care
What is Cytarabine Injection?
Cytarabine (also known as Ara-C) is a high-efficacy antimetabolite chemotherapeutic used primarily for the induction and consolidation treatment of hematologic cancers. It works by disrupting DNA synthesis, effectively targeting rapidly dividing cancer cells in the bone marrow and blood.
Who Uses Cytarabine?
Cytarabine injection is prescribed for adults and pediatric oncology patients undergoing chemotherapy regimens for hematologic malignancies (blood cancers) under the direct supervision of a qualified healthcare professional. It is used in hospitals, infusion centers, and specialized oncology clinics worldwide.
How to Use (Administration):
- For Hospital and Clinical Use Only.
-
Administered Only by Trained Medical Professionals via intravenous (IV) infusion, subcutaneous injection, or intrathecal (spinal) injection, depending on the specific treatment protocol.
-
Dosing is individualized based on treatment phase, patient body surface area, and combination with other chemotherapy drugs.
Do not self-administer. Strictly follow institutional protocols and oncologist instructions.
Product Category:
- Cytotoxic Chemotherapy Agent
- Antimetabolite Cancer Drug
- Oncology/Antineoplastic Medication
- Prescription-Only Hospital Injectable
Important Safety Information – Side Effects:
-
Common Side Effects: Nausea, vomiting, diarrhea, mouth sores (mucositis), low blood cell counts (anemia, leukopenia, thrombocytopenia), hair loss.
-
Serious Side Effects: Severe bone marrow suppression (risk of infection, bleeding), neurotoxicity, liver toxicity, pulmonary toxicity, allergic reactions.
-
Monitoring: Regular blood tests and oncologist follow-up are required during therapy.
Warning: Use only under strict medical supervision with regular lab and clinical monitoring. Not for use outside a hospital or supervised clinical setting.
Why Choose Cytarabine Injection by Pfizer Injectables?
-
International Oncology Standard: Trusted for decades in hematology-oncology practice.
-
Sterile, Stable Multi-Dose Vial: Ideal for hospital/clinical pharmacy use.
- Batch-Tested for Purity, Potency & Consistency
-
Preferred by Oncologists: Part of leading evidence-based leukemia and lymphoma protocols.
- Backed by Pfizer’s Expertise in Injectable Oncology Therapy
Pfizer Cytarabine Injection 1000 mg/50 mL: The Gold Standard Chemotherapy for AML, ALL, CML, and Lymphoma. Order for your hospital or clinic today—trusted, reliable, and ready for critical cancer care.
Skip to content
